Press / Medias

Press / Medias

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 14, 2020

more +
Press / Medias

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Apr 17, 2020

more +
Press / Medias

Georges Rawadi interviewed on Europe 1 radio – World Obesity Day

Mar 4, 2020

more +
Press / Medias

LNC Therapeutics selected by BNP Paribas for its innovative approach to beat obesity

Nov 12, 2019

more +
Press / Medias

Avec plus de 140 millions d’euros levés, les startups ne ratent pas leur rentrée

Sep 6, 2019

more +
Press / Medias

LNC Therapeutics raises €6.2 million for the clinical development of new generation gut microbiome...

Sep 5, 2019

more +

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions